
(AP) - Pfizer and BioNTech have begun studying a COVID-19 vaccine tweaked to match to the omicron variant in healthy adults.
COVID-19 vaccine makers have been updating their shots in case global health authorities decide a change is needed.
The study announced Tuesday will include more than 1,400 volunteers ages 18 to 55.
Most already are vaccinated and will get boosters of the omicron-based vaccine or the original version.
Some unvaccinated volunteers will get three omicron-based doses.
The original vaccines still offer good protection against severe illness and death.
And a booster improves the chances of avoiding even a milder infection.


Canoe journey of Ḵéex̱’ Yaakw’ Ḵwáan seeking community assistance
US Coast Guard medevacs passenger near Sitka
Former Alaska AG charged with sex abuse
Memorial Day observances in Juneau to be held Monday
High school graduations, SafeGrad set for Sunday in Juneau
Federal government sues Alaska over fishing on refuge river
Sealaska board adds $25M to shareholder permanent fund
Juneau woman cited after alleging false kidnapping report
University of Alaska Board of Regents to hold in-person board meeting
Alaska's largest natural gas utility being sold for $800M
NWS says 'great' weather all across Southeast this weekend
Juneau sustainability commission seeks $4M in 1% sales tax funding